Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
Collinson PO, Gaze DC, Thokala P, Goodacre S
Record ID 32011000821
English
Authors' recommendations:
Study found that the measurement of high-sensitivity cardiac troponin is the best single marker in patients presenting with chest pain and that additional measurement of myoglobin or creatine kinase MB is not clinically effective or cost-effective, copeptin measurement is not recommended and heart-type fatty acid-binding protein (H-FABP) requires further investigation before it can be recommended for simultaneous measurement with high-sensitivity troponin.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.hta.ac.uk/2267
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Biomarkers
- Cardiovascular Diseases
- Emergency Service, Hospital
- Sensitivity and Specificity
- Time Factors
- Troponin
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
<p>2013 Queen's Printer and Controller of HMSO</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.